0001209191-22-000122.txt : 20220103
0001209191-22-000122.hdr.sgml : 20220103
20220103160324
ACCESSION NUMBER: 0001209191-22-000122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211230
FILED AS OF DATE: 20220103
DATE AS OF CHANGE: 20220103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halkias Theodore
CENTRAL INDEX KEY: 0001855972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40332
FILM NUMBER: 22502040
MAIL ADDRESS:
STREET 1: C/O AGILON HEALTH, INC.
STREET 2: 1 WORLD TRADE CENTER, SUITE 2000
CITY: LONG BEACH
STATE: CA
ZIP: 90831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: agilon health, inc.
CENTRAL INDEX KEY: 0001831097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 371915147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
BUSINESS PHONE: 562-256-3800
MAIL ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
FORMER COMPANY:
FORMER CONFORMED NAME: Agilon Health Topco, Inc.
DATE OF NAME CHANGE: 20201103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-30
0
0001831097
agilon health, inc.
AGL
0001855972
Halkias Theodore
C/O AGILON HEALTH, INC.
1 WORLD TRADE CENTER, SUITE 2000
LONG BEACH
CA
90831
0
1
0
0
Chief Business Officer
Common Stock
2021-12-30
4
M
0
12113
1.00
A
17547
D
Common Stock
2021-12-30
4
S
0
12113
27.54
D
5434
D
Common Stock
2021-12-31
4
M
0
1162
1.00
A
6596
D
Common Stock
2021-12-31
4
S
0
1162
27.55
D
5434
D
Options (Rights to Buy)
1.00
2021-12-30
4
M
0
12113
0.00
D
2027-04-27
Common Stock
12113
1702609
D
Options (Rights to Buy)
1.00
2021-12-31
4
M
0
1162
0.00
D
2027-04-27
Common Stock
1162
1701447
D
Includes restricted stock units.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021.
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
2022-01-03